The blockade of TGF-β in colon cancer unleashed a potent and endured cytotoxic T-cell response against cancer cells, inhibited metastases, and rendered metastatic colon cancer more susceptible to anti-PD-1-PD-L1 therapy [32]. Here, CD274 is linked to colonic neoplasm.